-bep
Engineered binding proteins that are not built from antibody parts.
- Drugs ending in -bep: 7
- Approved somewhere: 0
- With a US drug page: 1
- Stem
- -bep
- Class
- Engineered binding proteins that are not built from antibody parts
Approved and clinical-stage drugs in ChEMBL whose names ending in -bep, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Lerodalcibep | Phase 3 | PCSK9 | Subtilisin/kexin type 9 inhibitor |
| Dazodalibep | Phase 3 | CD40LG | CD40 ligand antagonist |
| Ensovibep | Phase 3 | S | Spike glycoprotein inhibitor |
| Izokibep | Phase 3 | IL17A | Interleukin 17A inhibitor |
| Taldefgrobep alfa | Phase 3 | — | — |
| Elarekibep | Phase 2 | — | — |
| Palsucibep pegol | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO